AzTrials
AzTrials

Child Sexual AbuseEMORECNCT05383235

Facial Emotion Recognition in Patients Who Committed Sexual Assault Against Children: an EEG Study

A study testing ROUTINE CARE and Facial emotion stimuli prensentation task with EEG recording and facial emotion recognition task in people with Child Sexual Abuse and Emotion Recognition, run by Hôpital le Vinatier at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to compare the emotional processing in sexual offenders against children versus healthy volunteers using an objective electrophysiological measurement (EEG) during a facial emotion stimuli presentation task. Read more about this study

Who is it for?
Ages 25 to 55 years, men onlyHealthy volunteers can take part
Conditions the study is for
Child Sexual Abuse, Emotion Recognition
What is being tested?
ROUTINE CARE and Facial emotion stimuli prensentation task with EEG recording and facial emotion recognition task
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteFrance
Study dates
12 Jul 2022to 15 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 55 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Right-handed ;
  • Without criminal background ;
  • Without any DSM-5 psychiatric disorder (past or present, personal or familial in a first-degree relative) ;
  • Non-caregiver employee of Le Vinatier Hospital Center.

Who cannot join

  • Intellectual disability (identified during routine care in the referral platform for treatment of sexual offenders);
  • Poor understanding of tests and scales instructions ;
  • Neurological or neurodevelopmental history resulting in cognitive impairment with loss of autonomy ;
  • Gardianship or other tutelage measure
  • Healthy controls :
  • Intellectual disability (using fNART if clinical suspicion during run-in period);
Show all 9Show fewer
  • Poor understanding of tests and scales instructions ;
  • Neurological or neurodevelopmental history resulting in cognitive impairment with loss of autonomy ;
  • Gardianship or other tutelage measure.

Trial locations and contacts

1 site in 1 country.

France1 site
  • Centre Hospitalier Le Vinatier

    Bron, Auvergne-Rhône-Alpes, 69678

Other trials in France

About this study

This study aims to compare the emotional processing in sexual offenders against children versus healthy volunteers using an objective electrophysiological measurement (EEG) during a facial emotion stimuli presentation task. Secondary goal is to assess emotion recognition performances in this population and evaluate the impact of various factors on these performances (type of emotion, age and sex of person expressing the emotion, neuropsychological and cognitive abilities of the subjects).

Read the detailed description

Sexual abuse is a major public health issue. Apart from medical care of victims, it appears essential to intervene with sexual offenders for prevention purposes (from primary prevention to avoid a first sexual abuse to secondary and tertiary prevention to avoid recurrence). In order to improve those prevention strategies, further understanding of offenders neuropsychological and cognitive processes is needed.

Facial emotion recognition capacities, that play a major role in social cognition and generation of appropriate social behavior, has been the subject of few studies in sexual offenders. These studies show heterogeneous results and only one of them specifically targets sexual offenders against children. Furthermore, no study has investigated facial emotion recognition in this population with an objective measurement of emotional processing, such as electroencephalographic (EEG) activity. LPP (late positive potential) amplitude, measured in EEG, is a marker of emotional processing and appears to be modified in particular populations (eg. psychopaths) in response to negative visual stimuli compared to positive stimuli.

The investigators aim to determine whether LPP amplitude in response to negative facial expressions is modified in sexual offenders against children compared to healthy volunteers and compared to amplitude in response to positive facial expressions.

Effect of facial emotion characteristics (type of emotion, age and sex of person expressing the emotion) on EEG response will be assessed.

Various neuropsychological and cognitive characteristics (facial emotion recognition, theory of mind, psychopathic traits, childhood trauma, and alexithymia) of patients and controls will also be measured through neuropsychological evaluation and completion of scales and questionnaires, in order to investigate the impact of those factors on facial emotion recognition performances.

Being tested
ROUTINE CARE, Facial emotion stimuli prensentation task with EEG recording and facial emotion recognition task
Keywords
facial emotion recognition, sexual offenders against children, LPP

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ROUTINE CAREOther

    1. ROUTINE CARE : retrieval of sociodemographic characteristics, medical and psychological assessment, multidisciplinary meeting about the patient
  • Facial emotion stimuli prensentation task with EEG recording and facial emotion recognition taskDevice

    Also called Neuropsychological evaluation

    1. RUN-IN PERIOD :
    • Eligibility criteria will be assessed during the multidisciplinary meeting;
    • Study presentation, delivery of the information note and consent form; 3. STUDY:
    • Collection of consent form;
    • Facial emotion stimuli presentation task with EEG recording and facial emotion recording task;
    • Neuropsychological evaluation (TOM-15);
    • Scales and questionnaires (TAS-20, PCL-R SV, CECAQ, QCAE);
    • Debriefing.
Study groups in NCT05383235
Study groupRoleWhat they receive
Sexual offenders against childrenExperimentalsexual offenders against children
Receives: Other: ROUTINE CARE; Device: Facial emotion stimuli prensentation task with EEG recording and facial emotion recognition task
Healthy controlsActive comparatorHealthy controls
Receives: Device: Facial emotion stimuli prensentation task with EEG recording and facial emotion recognition task

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Amplitude of LPP during the facial emotion stimuli presentation task

    The facial emotion stimuli presentation task is based on pictures from the Radbout Faces Database (RaFD). It includes pictures of male and female subjects, adults and children expressing positive, neutral or negative emotion.

    During the task, cerebral activity will be recorded by EEG to measure amplitude and latency of the LPP (Late Positive Potential).

    Measured: one day

Secondary outcomes (6)
  1. Facial emotion recognition abilities

    Subjects and controls will be presented with facial emotion stimuli from the Radbout Faces Database (RaFD). It includes pictures of male and female subjects, adults and children expressing positive, neutral or negative emotion.

    We will measure recognition abilities (% correct response rate, response time, intensity and valence ratings).

    Measured: one day

  2. TOM-15 (Theory Of Mind 15)

    validated test for assessment of theory of mind

    Measured: one day

  3. TAS20 (Toronto Alexithymia Scale 20)

    validated scale for assessment of alexithymia Scores vary from 20/100 (low level of alexithymia) to 100/100 (high level of alexithymia)

    Measured: one day

  4. PCL-R SV (Psychopathy Checklist Revised - Short Version)

    validated checklist for assessment of psychopathy Scores vary from 0/24 (no psychopathic traits) to 24/24 (high level of psychopathic traits)

    Measured: one day

  5. QCAE (Questionnaire of Cognitive and Affective Empathy)

    validated questionnaire for assessment of cognitive and affective empathy Affective empathy scores vary from 12/48 (low level of affective empathy) to 48/48 (high level of affective empathy).

    Cognitive empathy scores vary from 19/76 (low level of cognitive empathy) to 76/76 (high level of cognitive empathy).

    Total empathy scores vary from 31/124 (low level of empathy) to 124/124 (high level of empathy).

    Measured: one day

  6. CECA-Q (Childhood Experiences of Care and Abuse - Questionnaire)

    validated questionnaire for assessment of childhood experience of care and abuse Global parental antipathy scores vary from 20/160 (low level of parental antipathy) to 160/160 (high level of parental antipathy).

    Neglect scores vary from 20/160 (low level of neglect) to 160/160 (high level of neglect).

    Physical abuses scores vary from 0/8 (no physical abuses) to 8/8 (high level of physical abuses during childhood) Scores of sexual abuse vary from 0 (no sexual abuse) à 7 (serious sexual abuse) Prevalence of psychological abuse vary from 0/34 (no psychological abuse) to 34/34 (multiple psychological abuses) Frequence of psychological abuse vary from 0/102 ( no psychological abuse) to 102/102 (frequent psychological abuse)

    Measured: one day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 May 2022
  2. Study start12 Jul 2022
  3. Primary completion15 May 2025
  4. Study completion15 May 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
PATIENTS: 1. ROUTINE CARE : retrieval of sociodemographic characteristics, medical and psychological assessment, multidisciplinary meeting 2. RUN-IN PERIOD: * Eligibility criteria will be assessed during the multidisciplinary meeting * Delivery of the information note 3. STUDY: * Collection of consent form * Facial emotion stimuli presentation task with EEG recording and facial emotion recognition task * Neuropsychological evaluation * Scales + questionnaires * Debriefing CONTROLS: 1. RUN-IN PERIOD phone call: * Study presentation * Retrieval of sociodemographic characteristics including age and educational level for matching with patients * Assessment of eligibility criteria * Psychiatric assessment with MINI 5.0 evaluation 2. STUDY: * Delivery of the information note * Collection of consent form * Facial emotion stimuli presentation task with EEG recording and facial emotion recognition task * Neuropsychological evaluation * Scales + questionnaires * Debriefing
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05383235
Sponsor's protocol ID
2021-A02763-38
Acronym
EMOREC
Status last verified
Jul 2025
First submitted
20 Apr 2022
Last updated
24 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing ROUTINE CARE and Facial emotion stimuli prensentation task with EEG recording and facial emotion recognition task in people with Child Sexual Abuse and Emotion Recognition, run by Hôpital le Vinatier at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Amplitude of LPP during the facial emotion stimuli presentation task (time frame: one day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in